Brown, A. M. Et Al. 2023. TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis. CANCER MEDICINE , vol.12, no.3 , 2590-2599.

Brown, A. M., Kassab, I., Massani, M., Townsend, W., Singal, A. G., Soydal, C., ... Moreno-Luna, L.(2023). TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis. CANCER MEDICINE , vol.12, no.3, 2590-2599.

Brown, Andrew Et Al. "TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis," CANCER MEDICINE , vol.12, no.3, 2590-2599, 2023

Brown, Andrew M. Et Al. "TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis." CANCER MEDICINE , vol.12, no.3, pp.2590-2599, 2023

Brown, A. M. Et Al. (2023) . "TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis." CANCER MEDICINE , vol.12, no.3, pp.2590-2599.

@article{article, author={Andrew M. Brown Et Al. }, title={TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis}, journal={CANCER MEDICINE}, year=2023, pages={2590-2599} }